(E)-6-Hexadecenal

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (E)-6-Hexadecenal
• 英文别名: (E)-hexadec-6-enal
• 化学式: C₁₆H₃₀O
• 分子量: 238.41
• InChiKey: IGGMOQLBTZJSGX-ZHACJKMWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  17
• 可旋转键数：
  13
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• AGRICULTURAL PHEROMONE COMPOSITIONS COMPRISING POSITIONAL ISOMERS
  申请人：PROVIVI, INC.

  公开号：US20170135343A1

  公开（公告）日：2017-05-18

  The present disclosure provides pheromone compositions. In some aspects, the compositions taught herein comprise a pheromone chemically corresponding to the pheromone naturally produced by a given insect, along with at least one positional isomer of said pheromone. In various aspects, pheromone compositions of the present disclosure are able to modulate the response of the insect based on the ratio of natural pheromone to its positional isomer.

  本公开提供信息素组合物。在某些方面，本文所教授的组合物包括一种与某种昆虫自然产生的信息素在化学上相对应的信息素，以及至少一种该信息素的位置异构体。在各个方面，本公开的信息素组合物能够通过自然信息素与其位置异构体的比例来调节昆虫的反应。
• METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES
  申请人：Children's Medical Center Corporation

  公开号：EP2575824A2

  公开（公告）日：2013-04-10
• US9657046B2
  申请人：——

  公开号：US9657046B2

  公开（公告）日：2017-05-23
• [EN] METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES<br/>[FR] PROCÉDÉS POUR LE TRAITEMENT ET LA PRÉVENTION DE MALADIES INFLAMMATOIRES
  申请人：CHILDRENS MEDICAL CENTER

  公开号：WO2011149881A2

  公开（公告）日：2011-12-01

  The inventors demonstrate that treatment of young, suckling mice with a glycolipid derived from Helicobacter pylori activates NKT cells in a CD1d-restricted fashion, and is protective against AHR in a model of allergen-induced asthma. The inventors further found that this protective effect can be transferred by NKT cells exposed to the glycolipid, and is associated with the expansion of a suppressive double-negative NKT cells and Foxp3+ TReg cells. The inventors also demonstrate herein that pre-treatment of adult mice with a glycolipid derived from Helicobacter pylori partially suppresses airway hyperreactivity and inhibits BAL inflammation in an ozone-exposure model. Accordingly, provided herein are compositions and methods for the treatment and prevention of inflammatory diseases, such as asthma or autoimmune diseases, in a subject in need thereof.